(Q51833897)

English

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

author name string

David A Begley

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Dorothy Tripodi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Judith B Winkler

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Lameh Fananapazir

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Pacing and Clinical Electrophysiology

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

26

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

9

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

1887-1896

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Molecular basis of familial cardiomyopathies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Implantable Cardioverter Defibrillators in Cardiovascular Practice: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9592.2003.00285.X

21 January 2018

Identifiers

10.1046/J.1460-9592.2003.00285.X

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/12930505

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51833897&oldid=1234562988"